UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▼ | Disease Ontology |
---|---|---|---|---|---|
A0A7J8J2E0 | peptidylamidoglycolate lyase |
|
1 | 0 |
|
A0A7J8CZK3 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A7J8BJE7 | Pannexin 2 |
|
1 | 0 |
|
A0A7J8GNR9 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7J8I4N8 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8GPI2 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7J8DPD7 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7J8I4N0 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8HYF8 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
2 | 0 |
|
A0A7J8HXK8 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
2 | 0 |
|
A0A3T0CNB6 | Rhodopsin |
|
2 | 0 |
|
A0A7J8J4U4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8I3R3 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A7J8CZA5 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A7J8DCW3 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A7J8J1H0 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A7J8BX81 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7J8GQZ4 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A7J8DBP7 | Hyaluronidase |
|
1 | 0 |
|
A0A7J8DBC9 | Hyaluronidase |
|
1 | 0 |
|
A0A7J8DAQ0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8I528 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8BKK1 | Pannexin |
|
1 | 0 |
|
A0A7J8I3U6 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7J8B823 | Hemopexin |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024